Skip to search formSkip to main contentSkip to account menu

KCB 328

Known as: KCB-328 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Tracking Spatial and Temporal Cotton ET Patterns with a Normalized Difference Vegetation Index
Crop coefficients (Kc) are widely used to estimate crop evapotranspiration (ETc) for determining irrigation scheduling… 
Review
2003
Review
2003
IKr channel blockers: novel antiarrhythmic agents.
There have been extensive efforts to develop I(Kr) channel blockers as a new antiarrhythmic agent for atrial or ventricular… 
2003
2003
Differential Recovery of Action Potential Duration and HERG Currents from the Effects of Two Methanesulfonamide Class III Antiarrhythmic Agents, KCB-328 and Dofetilide
A novel pure class III antiarrhythmic agent, 1-(2-amino-4-methanesulfonamidophenoxy)-2-[N-(3,4-dimethoxyphen-ethyl)-N-methylamino… 
2003
2003
Contrasting roles of a novel K+ channel blocker and a K+ channel opener on electro-mechanical activity in canine heart tissue.
2002
2002
Open channel block by KCB-328 [1-(2-amino-4-methanesulfonamidophenoxy)-2-[N-(3,4-dimethoxyphenethyl)-N-methylamino]ethane hydrochloride] of the heterologously expressed human ether-a-go-go-related…
KCB-328 [1-(2-amino-4-methanesulfonamidophenoxy)-2-[N-(3,4-dimethoxyphenethyl)-N-methylamino]ethane hydrochloride] is a newly… 
2001
2001
Electrophysiologic and Antiarrhythmic Effects of the New Class III Antiarrhythmic Drug KCB-328 in Experimental Canine Atrial Flutter
Background: The electrophysiologic and antiarrhythmic effects of a new class III antiarrhythmic drug (KCB-328), a delayed… 
2000
2000
QT-prolonging class I drug, disopyramide, does not aggravate but suppresses adrenaline-induced arrhythmias. Comparison with cibenzoline and pilsicainide.
1998
1998
MS‐551 and KCB‐328, two class III drugs aggravated adrenaline‐induced arrhythmias
We investigated the proarrhythmic effects of MS‐551 and KCB‐328, class III antiarrhythmic drugs using adrenaline‐induced… 
1998
1998
Antiarrhythmic effects of a novel class III drug, KCB-328, on canine ventricular arrhythmia models.
KCB-328 is a newly synthesized class III drug. To determine whether this drug has antiarrhythmic or proarrhythmic effects, we… 
1998
1998
KCB-328: a novel class III antiarrhythmic agent with little reverse frequency dependence in isolated guinea pig myocardium.
The effects of 1-(2-amino-4-methanesulfonamidophenoxy)-2-[N-(3,4-dimethoxypheneth yl)-N-methylamino] ethane hydrochloride (KCB… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)